Abstract
An early dysphoric response following treatment with antipsychotic medication may lead to discontinuation of antipsychotic medication and thereby to relapse and rehospitalisation. Also cannabis use has found to be related to non-adherence to therapy. In the present study we examined whether 1) an early dysphoric response to antipsychotic medication, 2) cannabis use were related to discontinuation of antipsychotic medication in patients with early psychosis, and 3) whether there were differences in discontinuation between olanzapine compared with risperidone.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
